In recent years, the global scientific research field has witnessed an intense emergence of disruptive achievements. In 2024, using artificial intelligence (AI) technology, a Chinese-Australian team ...
This activity was supported by Contract No. 200-2011-38807 with the Centers for Disease Control and Prevention. Any opinions, findings, conclusions, or recommendations expressed in this publication do ...
– Paradigm, a healthcare technology company focused on improving access to clinical research for patients, launched with $203 million in Series A funding. – Conceived by ARCH Venture Partners, and ...
In the scope of this paper, a paradigm is a general modeling framework or a distinct set of methodologies to solve a class of tasks. For instance, sequence labeling is a mainstream paradigm for named ...
Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst. F-Prime Capital, LUX Capital, ...
– Paradigm Health’s acquisition of Flatiron Health’s Clinical Research Business, coupled with a long-term strategic partnership, marks a structural shift in how oncology trials are conducted and how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results